- Nachrichtendetail
-
06.05.2024 13:56:10 - dpa-AFX: *BMY :OPDIVO + YERVOY GRANTED EMA VALIDATION FOR FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Bristol-Myers Squibb Co | 850501 | NYSE | 42,250 | 24.06.24 20:29:35 | +0,320 | +0,76% | 42,240 | 42,250 | 41,260 | 41,930 |
